Dr. Razavi is involved with numerous clinical trials assessing the efficacy of cutting edge technology in the field of cardiac electrophysiology. He has founded multiple medical device startups including: Saranas, a smart cardiology sheath, and Nanolinea, conductive nanotechnology for the treatment of arrhythmia. Additionally, Dr. Razavi has supervised the development of a number of technologies in collaboration with Rice University and Texas A&M and has over 20 patents to his name.
See PublicationsTexas Heart Institute Positions
- Director, Electrophysiology Clinical Research & Innovations
- Teaching Staff, Cardiovascular Disease Fellowship
- Editorial Consultant, Texas Heart Institute Journal
- Teaching Staff, Clinical Cardiac Electrophysiology Fellowship
Current Projects
Interests
Education
-
Medical School:
Medical College Of Pennsylvania
-
Residency:
Mayo Graduate School of Medicine
-
Fellowships:
Mayo Graduate School of Medicine
Academic & Clinical Affiliations
Certifications
- American Board of Internal Medicine, Cardiology (2001, 2011)
- American Board of Internal Medicine, Clinical Cardiology Electrophysiology (2002, 2012)
Publications
Recent News
THI invention receives FDA clearance
A new device invented by Texas Heart Institute (THI) became the first and only device to be cleared by the FDA for early...
THI Discusses Heart Health on Texas Public Radio
Dr. Mehdi Razavi, Director of Electrophysiology Clinical Research and Innovations, participated in Texas Public Radio’s live, call-in talk show “The Source”. Many...
Texas Heart Institute Conducting New Clinical Trial to Test Innovative New Early Bird™ Bleed Monitoring System
The Saranas-Owned Technology was invented at Texas Heart Institute. November 20, 2018 (Houston, TX) – Texas Heart Institute is currently...